Oral Decitabine and Cedazuridine Plus Venetoclax for Older or Unfit Patients With AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study
Lancet Haematol 2024 Mar 04;[EPub Ahead of Print], A Bazinet, G Garcia-Manero, N Short, Y Alvarado, A Bataller, T Abuasab, R Islam, K Montalbano, G Issa, A Maiti, M Yilmaz, N Jain, L Masarova, S Kornblau, E Jabbour, G Montalban-Bravo, CR Rausch, S Pierce, CD DiNardo, T Kadia, N Daver, M Konopleva, X Huang, H Kantarjian, F RavandiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.